Fast and Robust Hybridoma Optimization

What is Hybridoma Optimization?

Hybridoma optimization refers to the improvement and enhancement of hybridoma cell lines to increase the yield, quality and stability of monoclonal antibodies. Hybridoma cells are hybrid cells produced by the fusion of B cells with myeloma cells. The resulting cell line has both characteristics and can continuously produce monoclonal antibodies. However, the antibody yield or quality of these cells is not constant, so optimization is needed. Hybridoma optimization may involve a variety of techniques, such as subcloning to screen high-yield clones, gene amplification to increase antibody gene expression, and optimizing culture conditions to improve production capacity and cell health. Screening and optimization of antibody characteristics are also part of the screening process. In addition, antibody stability and scalability are also critical to ensure that hybridoma cell lines can reliably produce large quantities of monoclonal antibodies over the long term to meet the needs of research, diagnostic or therapeutic applications.

Applications of Hybridoma Optimization Services

mprove the yield and stability of monoclonal antibodies.

Produce highly specific antibodies for disease detection methods.

Provide stable and efficient antibodies for scientific research.

Used for subsequent antibody engineering and humanization, and support the development of biosimilars or antibody upgrades.

Optimize hybridoma cells for food safety, environmental monitoring and other fields, and customize the production of specific antibodies.

Why Choose Creative Diagnostics' Hybridoma Optimization Services?

BD FACSymphony™ Flow Cytometer

Cytiva AKTA™ Pure 25

Sartorius Stedim Biotech Biostat®

As a trusted provider of Hybridoma Optimization Services, Creative Diagnostics is dedicated to delivering tailored solutions to support scientific research and diagnostic development. With decades of expertise, we offer a full spectrum of hybridoma optimization technologies to enhance antibody yield, specificity, and stability. We offer service for all steps of the production process, from hybridoma cell line screening and genetic engineering to culture condition optimization and downstream quality control. We perform these optimizations step by step to make monoclonal antibodies with high affinity and reproducibility of each batch, and excellent biological activity for various research and diagnostic applications. Our comprehensive services include:

System optimization at multiple stages, including cell line screening, clone stability assessment, antibody expression improvement, culture medium optimization, and comprehensive improvement of yield and purity.

Utilize automated equipment and high-throughput screening technology to improve screening efficiency and accuracy.

Combine molecular biology technology and functional screening technology to ensure the genetic stability and functional specificity of antibody expression.

Optimize culture medium composition, feeding strategy and culture conditions to maximize antibody production while ensuring cell growth stability and antibody quality.

Long-term passage experiments and stability assessment services ensure that the selected hybridoma cell lines maintain stable antibody expression levels in long-term culture.

Our Services

In order to meet the diverse needs of scientific research and diagnostics for high-performance monoclonal antibodies, we provide comprehensive Hybridoma Optimization Services, covering multiple core technical supports such as hybridoma cell screening, subcloning, yield improvement, and stability optimization. Through mature optimization strategies and strict quality control systems, we ensure that the optimized hybridoma cell lines have high antibody yields, good stability, and sustained expression capabilities, laying a solid foundation for subsequent functional analysis, structural research, quantitative detection, and product development. Our main services include:

Hybridoma Cell Screening and Cloning Optimization

Use limiting dilution, semi-solid culture or automated screening system for monoclonal screening
Multiple rounds of subcloning to ensure clone purity and genetic stability
Select high-affinity, high-expression cell lines for subsequent development

Antibody Expression Yield Optimization

Optimize medium components, additives and culture parameters (such as temperature, pH) to increase expression
Support various culture methods such as suspension culture and microcarrier culture
Provide yield testing from small to pilot scale

Antibody Affinity and Specificity Improvement

Use in vitro affinity maturation strategies (such as chain mutation and reassortment) to improve antibody function
High-throughput screening to improve target binding specificity and biological activity

Cell Genetic Stability Analysis

Detect chromosome stability and consistency of immunoglobulin expression
Perform long-term passage tests to evaluate the stability of cell lines in industrial applications

Antibody Subtype and Function Verification

Evaluate antibody type and activity through ELISA, Western blot, flow cytometry and other methods
Confirm the correct expression and conformational integrity of antibody heavy chain/light chain

Rescue Fusion

When hybridoma cell antibody expression decreases or growth stagnates, the re-fusion technology is used for "resuscitation"
Re-screen and establish new monoclonal antibody cell lines to ensure that antibody function is restored

Antibody Labeling Services Process

Clearly define optimization goals, cell types, and project feasibility.

Select appropriate hybridoma cells to improve antibody expression levels and stability.

Develop optimization plans, adjust culture conditions and screening processes.

Detect antibody production and activity, and verify optimization effects.

Achieve cell line scale-up culture, and provide technical support and services.

Case Study

Case Study

Creative Diagnostics tested the effectiveness of the Hybridoma Optimization service in improving antibody screening efficiency. The horizontal axis in the figure is the screening cycle (Week 1 to Week 4), and the vertical axis is the number of positive antibody clones obtained in each screening cycle. By comparing the gray dotted line with the blue solid line, it can be intuitively observed that the number of positive clones grew slowly before optimization, reaching only 22 in Week 4, while after optimization, the number of positive clones increased significantly in the same period, increasing to 40, with a growth rate of 82%.

FAQs About Hybridoma Optimization Services

What is hybridoma optimization?

Hybridoma optimization is the process of improving the growth, stability and productivity of hybridoma cell lines. It can include re-fusion of the hybridoma with myeloma cells, creation and screening of stable clones, media optimization and other methods. Hybridoma optimization is frequently necessary when a hybridoma becomes less productive or viable over time, resulting in poor yields or quality of antibodies for downstream research or therapeutic use.

What applications benefit from antibody labeling?

Re-fusion is a step in the hybridoma optimization process, where the original hybridoma cells are fused with the myeloma cells once more to produce new stable clones. If the original hybridoma has lost growth or productivity, re-fusion can help to restore antibody production and increase the robustness of the cell line.

Can hybridoma optimization lead to changes in monoclonal antibody affinity or specificity?

Hybridoma optimization is typically used to improve cell growth and productivity. However, some methods such as clone selection and screening during the process can help to identify variants with better antibody affinity or specificity.

Inquiry Basket

Loading ......

Inquiry